Relay Therapeutics, Inc.RLAYNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank71
3Y CAGR+2.0%
5Y CAGR+21.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+2.0%/yr
vs +56.5%/yr prior
5Y CAGR
+21.2%/yr
Recent deceleration
Acceleration
-54.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $261.38M | -18.1% |
| 2024 | $319.09M | -3.3% |
| 2023 | $330.02M | +34.0% |
| 2022 | $246.35M | +42.7% |
| 2021 | $172.65M | +72.9% |
| 2020 | $99.86M | +42.0% |
| 2019 | $70.31M | +71.3% |
| 2018 | $41.03M | - |